ABCL - AbCellera Biologics Inc.
2.03
0.020 0.985%
Share volume: 3,991,257
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$2.01
0.02
0.01%
Summary score
40%
Profitability
39%
Dept financing
24%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.12%
Return on assets
-1.17%
Return on sales
-584.04%
Return on invested capital
4.87%
Total debt ratio
21.46%
Debt ratio change over timeo
-5.9%
Current Ratio
9.22%
Quick Ratio
12.1%
Cash Position Ratio
3.8%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-4.48%
Return on sales
-1409.04%
Return on invested capital
0%
Total debt ratio
22.55%
Debt ratio change over timeo
0%
Current Ratio
10.06%
Quick Ratio
0%
Cash Position Ratio
1.96%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.54%
Return on sales
-1479.57%
Return on invested capital
0%
Total debt ratio
23.9%
Debt ratio change over time
0%
Current Ratio
10.15%
Quick Ratio
0%
Cash Position Ratio
2.11%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-59.02%
Return on assets
-50.86%
Return on sales
11726.46%
Return on invested capital
-2.3%
Total debt ratio
-590.41%
Debt ratio change over time
-5.9%
Current Ratio
-400.87%
Quick Ratio
-542.37%
Cash Position Ratio
-374.24%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABCL | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 1.12% | 14.28% | 9.23% | 0% |
| Return on assets | -1.17% | 4.23% | 3.2% | 0% |
| Return on sales | -584.04% | 27.89% | 25.03% | 0% |
| Return on invested capital | 4.87% | 8.36% | 9.37% | 0% |
| Profitability | 15% | 97% | 83% | 0% |
| Total debt ratio | 21.46% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | -5.9% | -11.36% | -57.43% | 0% |
| Dept financing | 7% | 25% | 18% | 25% |
| Current Ratio | 10.06% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 1.96% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 6% | 9% | 0% |
| Short-term ratios | ABCL | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -4.48% | 4.32% | 3.49% | 0% |
| Return on sales | -1409.04% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 22.55% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 18% | 0% |
| Current Ratio | 10.06% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 1.96% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 30% | 32% | 0% |
